Radiopharm Theranostics Limited engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs.
Radiopharm Theranostics stock last closed at $4.20, down 2.33% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Biotechnology industry by N/A percentage points. Radiopharm Theranostics stock is currently +20.14% from its 52-week low of $3.50, and -91.74% from its 52-week high of $50.82.
There are currently 2.17B shares of RADX outstanding. The market value of RADX is $27.38M. In the last 24 hours, 12,919 RADX shares were traded.
How to Buy Radiopharm Theranostics Stock
Wondering how to invest in Radiopharm Theranostics stock? Here's how.
Decide where to buy Radiopharm Theranostics stock: You need to decide on a stock brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you determine where to buy Radiopharm Theranostics stock.
Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
Deposit money your investment account: Pick your method of payment and add your info.
Evaluate Radiopharm Theranostics stock: The Radiopharm Theranostics ticker symbol is RADX. Is Radiopharm Theranostics stock a good investment? Should you buy shares of RADX? How do RADX's underlying business fundamentals look? Do top analysts think Radiopharm Theranostics is a good buy? Why has RADX's stock price moved recently? (Hint: Our stock market research tools can help you evaluate if RADX is a good stock to buy).
Execute your RADX trade: Decide if you will purchase RADX shares at the current market price or use a limit order to purchase RADX stock at a particular price.
Get the latest scoop on your RADX position: Create a watchlist to watch your position in Radiopharm Theranostics shares.
Step 1: Decide where to buy Radiopharm Theranostics stock
You need an online brokerage account in order to access the NASDAQ market and buy RADX stock.
A brokerage account is an investment account that enables you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. eToro gives you:
Invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
Access to world markets: From Tech to Financial Services, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by opening an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open a brokerage account
Now that you've chosen the right brokerage, you'll need to fill out some personal information so you are able to invest in RADX today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Radiopharm Theranostics stock
After you have decided on the best place to buy Radiopharm Theranostics stock, it's important to research their stock prior to buying, so you truly comprehend the risk as well as the upside.
Radiopharm Theranostics Metrics
RADX Price
$4.20
1w %
-6.25%
1y %
N/A
5y %
N/A
P/E
-0.35x
P/B
0.82x
P/S
28.77x
PEG
N/A
Revenue
$1.06M
Earnings
-$25.69M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$27.38M
Next Earnings
N/A
Next Dividend
N/A
Radiopharm Theranostics Due Diligence Score
WallStreetZen was designed to help average investors perform better fundamental analysis in less time.
Last year, RADX revenue was $1.06M. Over the last 2 year, RADX's revenue has grown by 130.81% per year. This was faster than the Biotechnology industry average of 44.31%.
No, Radiopharm Theranostics doesn't provide an income stream by paying out dividends.
Get opinions from other traders
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Execute your RADX trade
There are two main order types:
Market order: A market order is an order to buy or sell a stock at the best price on the market. Market orders are generally fine for most investors.
Limit order: A limit order is an order to buy or sell a stock at a specific price (or better). If you want to be certain you're buying or selling at a specific price limit, use a limit order.
Click the Open button and eToro will place your order.
If you need more help with investing in stocks on eToro, click the helpful video below:
How much does it cost to buy one Radiopharm Theranostics share?
As of Apr 21, 2025, it costs $4.20 to buy one share of Radiopharm Theranostics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $2, you can buy 0.476 shares of RADX.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.